Today: 21 May 2026
Trump’s Greenland tariff threat sets up a tense week for global stocks
18 January 2026
2 mins read

Trump’s Greenland tariff threat sets up a tense week for global stocks

London, January 18, 2026, 17:03 GMT — The market has closed.

  • Trump renewed trade-war tensions by threatening new tariffs on eight European countries connected to Greenland.
  • Wall Street finished Friday nearly flat, with the S&P 500 settling at 6,940.01.
  • With holiday liquidity drying up, investors are turning their attention to a busy earnings calendar alongside critical U.S. court rulings and Fed announcements.

Global stock markets are bracing for volatility this week after President Donald Trump threatened new tariffs on eight European countries if the U.S. isn’t allowed to buy Greenland. He announced a 10% import tariff starting Feb. 1, set to jump to 25% on June 1 unless a deal is struck. The tariffs would hit Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland, and Britain.

Major equity benchmarks remain near their highs, with investors relying heavily on earnings to back current valuations. That leaves little margin for error. Tariffs usually bring ripple effects—retaliation, slower trade, and a further blow to already-fragile confidence.

The calendar isn’t offering much relief. U.S. markets will be closed Monday for Martin Luther King Jr. Day. Then, throughout the week, earnings from Netflix, Johnson & Johnson, and Intel are set to dominate. On top of that, the U.S. Supreme Court is set to hear President Trump’s bid to remove Federal Reserve Governor Lisa Cook. “Earnings actually carry the news cycle,” said Art Hogan, chief market strategist at B Riley Wealth. Reuters

Stocks ended the week cautiously. The Dow dipped 0.17% Friday, the S&P 500 eased 0.06%, and the Nasdaq fell 0.06%, all posting slight weekly losses. Treasury yields ticked up and the dollar remained steady. Anthony Saglimbene, chief market strategist at Ameriprise Financial, called the markets “flat-lining” ahead of upcoming earnings. Reuters

Europe’s STOXX 600 closed Friday flat at 614.38 points, marking its fifth consecutive weekly rise. Luxury stocks took a hit, led by Richemont which fell after a Bank of America downgrade. Meanwhile, Novo Nordisk surged amid renewed interest in Wegovy. Michael Field, Morningstar’s chief European equity strategist, cautioned that “the margin of safety that investors had previously is gone.” Reuters

Asia kicked off the day on edge. China’s securities regulator promised stricter oversight as the Shanghai Composite hovered close to a decade peak. Chinese exchanges also announced they will raise the minimum margin requirement for new loans from 80% to 100% starting Jan. 19, a step designed to temper the rapidly moving market.

Volatility is under scrutiny following Friday’s monthly options expiration, which some traders believe has kept the benchmark index stuck near the 7,000 mark. Options give investors the right to buy or sell at a set price by a certain date. After large expirations, market movements can intensify as hedges unwind. “Start moving around a bit more,” said Brent Kochuba, founder of SpotGamma. Reuters

The downside is clear: tariff threats turn into reality, and Europe strikes back fast, dragging stocks into a broader trade conflict just as investors fret over Fed leadership and central bank independence. With the U.S. holiday thinning liquidity early in the week, initial moves may appear more dramatic than they actually are.

Asia’s open on Monday will give the initial market cue, as traders focus on the euro, European risk proxies, and any official statements from European capitals. Then eyes turn to Netflix earnings on Tuesday and the Supreme Court hearing Wednesday. The Feb. 1 tariff deadline looms quietly in the background.

Stock Market Today

  • Stock Market Futures Fall on May 20, 2026, as Investors React to Nvidia Earnings
    May 20, 2026, 7:32 PM EDT. U.S. stock futures dropped Wednesday evening, reflecting investor caution after Nvidia ($NVDA) reported earnings. The AI chipmaker's results sparked debate over whether they met lofty expectations, influencing market sentiment ahead of Thursday's open. Futures contracts, which allow investors to buy or sell assets at a predetermined price for future delivery, indicated a tentative market tone. Traders are assessing Nvidia's outlook amid broader concerns about the tech sector's growth momentum and valuation pressures. This cautious stance highlights the sensitive market environment as investors balance strong earnings reports against economic headwinds and sector-specific risks.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Tencent stock price: 0700.HK closes at HK$617.50 as AI push and March results date come into focus
Previous Story

Tencent stock price: 0700.HK closes at HK$617.50 as AI push and March results date come into focus

Hermes stock: why RMS.PA slid on Friday and what investors watch next week
Next Story

Hermes stock: why RMS.PA slid on Friday and what investors watch next week

Go toTop